Classics in Chemical Neuroscience: Medetomidine

Area of Science:

• Pharmacology
• Toxicology
• Drug Chemistry

Background:

• Medetomidine is an FDA-approved α₂-adrenoreceptor agonist used in veterinary medicine.
• Dexmedetomidine, its active enantiomer, is used for human sedation and analgesia.
• Medetomidine is increasingly detected in illicit drug supplies.

Purpose of the Study:

• To review the history, chemistry, pharmacology, and DMPK of medetomidine.
• To discuss the emergence of medetomidine as an adulterant in the context of the opioid crisis.
• To highlight the challenges in reversing medetomidine's sedative effects.

Main Methods:

• Literature review of medetomidine's properties and illicit use.
• Analysis of its presence in seized drug samples and overdose cases.
• Examination of structure-activity relationships and pharmacokinetics.

Main Results:

• Medetomidine is present in illicit drug mixtures with fentanyl, xylazine, and others.
• It produces significant sedative effects that are not reversed by naloxone.
• Its low cost and lack of regulation contribute to its misuse.

Conclusions:

• Medetomidine's emergence as an adulterant poses a significant public health risk.
• Understanding its pharmacology is crucial for addressing the opioid crisis.
• Further research into detection and reversal strategies is needed.